Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Clinical trial NCT05080556 · RECRUITING

Trial details

NCT number: NCT05080556
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Relapsed Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Endometrioid Carcinoma High Grade Serous Carcinoma Ovary Cancer

Start date: 2023-05-24
Primary completion: 2026-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.